Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Down 37.8% in February

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a significant drop in short interest in February. As of February 13th, there was short interest totaling 4,350 shares, a drop of 37.8% from the January 29th total of 6,992 shares. Based on an average daily volume of 14,397 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily volume of 14,397 shares, the days-to-cover ratio is currently 0.3 days.

Carl Zeiss Meditec Stock Performance

Shares of CZMWY opened at $31.92 on Friday. Carl Zeiss Meditec has a fifty-two week low of $29.92 and a fifty-two week high of $76.28. The firm has a 50 day moving average price of $39.11 and a 200-day moving average price of $46.65.

Analyst Upgrades and Downgrades

CZMWY has been the topic of a number of research analyst reports. The Goldman Sachs Group lowered shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein lowered shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold”.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.